Innovis Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$6.26M Buy
12,366
+1,358
+12% +$724K 2.41% 16
2023
Q2
$5.74M Buy
11,008
+542
+5% +$292K 2.12% 17
2023
Q1
$6.03M Sell
10,466
-204
-2% -$115K 2.45% 13
2022
Q4
$5.88M Buy
+10,670
New +$5.65M 2.65% 12

Other funds holding TMO

Innovis Asset Management's TMO Position: Q3 2023 in Review

Innovis Asset Management increased its Thermo Fisher Scientific (TMO) stake by 12% in Q3 2023, buying an estimated $724K and bringing the position to 12,366 shares worth $6.26M. The position accounts for 2.41% of the portfolio, ranked #16.

Innovis Asset Management first reported a position in TMO in Q4 2022 and has held it in 4 quarters since. 2,366 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Innovis Asset Management held 12,366 shares of Thermo Fisher Scientific worth $6.26M as of Q3 2023.
  • Innovis Asset Management bought 1,358 Thermo Fisher Scientific shares in Q3 2023, an estimated $724K.
  • Thermo Fisher Scientific made up 2.41% of Innovis Asset Management's portfolio in Q3 2023, its #16 holding.
  • Innovis Asset Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 4 quarters since.
  • 2,366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.